![Abizer Gaslightwala](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 6 149 $ in data 31/05/2025
Mr. Abizer Gaslightwala is a President, Chief Executive Officer & Director at Akari Therapeutics Plc and a Senior Vice President at Jazz Pharmaceuticals Plc.
He is on the Board of Directors at Akari Therapeutics Plc.
He received his undergraduate degree from Cornell University, a graduate degree from Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/06/2026 | 614.856.000 ( 0,44% ) | 6 149 $ | 31/05/2025 |
| Società | Posizione | Inizio |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Amministratore Delegato | 21/04/2025 |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/10/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
